Cargando…
Important Differences Between Manufacturers When Transitioning From a Contemporary Cardiac Troponin Assay to a High-Sensitivity Cardiac Troponin Assay
Autores principales: | Kavsak, Peter A., Um, Kevin, Mondoux, Shawn, Paré, Guillaume, Ainsworth, Craig, Worster, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209364/ https://www.ncbi.nlm.nih.gov/pubmed/34169266 http://dx.doi.org/10.1016/j.cjco.2021.01.017 |
Ejemplares similares
-
Acute Phase Response and Non-Reproducible Elevated Concentrations with a High-Sensitivity Cardiac Troponin I Assay
por: Kavsak, Peter A., et al.
Publicado: (2021) -
Can the Addition of NT-proBNP and Glucose Measurements Improve the Prognostication of High-Sensitivity Cardiac Troponin Measurements for Patients with Suspected Acute Coronary Syndrome?
por: Kavsak, Peter A., et al.
Publicado: (2021) -
Disagreement between Cardiac Troponin Tests Yielding a Higher Incidence of Myocardial Injury in the Emergency Setting
por: Kavsak, Peter A., et al.
Publicado: (2021) -
Admission High-Sensitivity Cardiac Troponin vs a Biochemical Score for Predicting Mortality in Patients With COVID-19
por: Kavsak, Peter A., et al.
Publicado: (2020) -
Diagnostic Performance of Serial High-Sensitivity Cardiac Troponin Measurements in the Emergency Setting
por: Kavsak, Peter A., et al.
Publicado: (2021)